PT Diastika Biotekindo Tbk (ISX:CHEK) OCF Yield %: 0.00 (As of Jul. 13, 2026)


What is PT Diastika Biotekindo Tbk OCF Yield %?

PT Diastika Biotekindo Tbk ISX:CHEK +0.81% OCF Yield % is 0.00 as of Jul. 13, 2026. The stock has 1 warning sign investors should review. Among 852 Medical Devices & Instruments companies, PT Diastika Biotekindo Tbk ranks worse than 117370.77% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, PT Diastika Biotekindo Tbk's Trailing 12-Month Cash Flow from Operations is Rp0.00 Mil, and Market Cap is Rp510,053.10 Mil. Therefore, PT Diastika Biotekindo Tbk's OCF Yield % for today is 0.00%.

The historical rank and industry rank for PT Diastika Biotekindo Tbk's OCF Yield % or its related term are showing as below:


ISX:CHEK's OCF Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.725
* Ranked among companies with meaningful OCF Yield % only.

PT Diastika Biotekindo Tbk's OCF Margin % for the quarter that ended in . 20 was %.


PT Diastika Biotekindo Tbk OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


PT Diastika Biotekindo Tbk OCF Yield % Related Terms


PT Diastika Biotekindo Tbk OCF Yield % Historical Data

* Premium members only.

The historical data trend for PT Diastika Biotekindo Tbk's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Diastika Biotekindo Tbk OCF Yield % Chart

PT Diastika Biotekindo Tbk Annual Data
Trend
OCF Yield %

PT Diastika Biotekindo Tbk Semi-Annual Data
OCF Yield %

ISX:CHEK vs ABT, SYK, MDT: OCF Yield % Comparison

For the Medical Devices subindustry, PT Diastika Biotekindo Tbk's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Diastika Biotekindo Tbk OCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT Diastika Biotekindo Tbk's OCF Yield % distribution charts can be found below:

* The bar in red indicates where PT Diastika Biotekindo Tbk's OCF Yield % falls into.



PT Diastika Biotekindo Tbk OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

PT Diastika Biotekindo Tbk's OCF Yield % for the fiscal year that ended in . 20 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
= /
=N/A%

PT Diastika Biotekindo Tbk's annualized OCF Yield % for the quarter that ended in . 20 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
= * 1 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 0.00 mean?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a OCF Yield % of 0.00 as of Jul. 13, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on PT Diastika Biotekindo Tbk and its competitors. According to the industry distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 852 companies in the Medical Devices & Instruments industry.
Is PT Diastika Biotekindo Tbk's OCF Yield % too high?
PT Diastika Biotekindo Tbk's current OCF Yield % is 0.00. Based on the distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 852 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does PT Diastika Biotekindo Tbk's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 852 companies for OCF Yield %. This places PT Diastika Biotekindo Tbk in the lower half of its industry. The industry median OCF Yield % is 1.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.73, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on PT Diastika Biotekindo Tbk and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Diastika Biotekindo Tbk's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diastika Biotekindo Tbk stock overvalued right now?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For PT Diastika Biotekindo Tbk (ISX:CHEK), the current OCF Yield % is 0.00 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Diastika Biotekindo Tbk Business Description

Address Jalan Rawagelam V, Kawasan Industri Pulogadung, Block L, No. Kav 11-13, Gedung Etana Lantai 3, Desa/Kelurahan Jatinegara, Kec. Cakung, Kota Adm. Jakarta Timur, Jakarta, IDN, 13930
PT Diastika Biotekindo Tbk is engaged in providing medical and laboratory equipment solutions in Indonesia. It is engaged in the wholesale trading of laboratory equipment, pharmaceutical products, and medical devices for human use. The company is also involved in wholesale trading of radioactive substances and ionizing radiation generators, and undertakes activities related to the testing and/or calibration of medical devices, as well as the inspection of healthcare facilities and infrastructure. Its product offerings mainly include devices like hematology analyzer, pipette, hemoglobin testing system, etc. The company's operating segments are: Diagnostics Group, which generates the maximum revenue, and Life Sciences Group. Geographically, all of its revenue is derived from Indonesia.